These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9596088)

  • 1. Comparative strategies to induce long-term graft acceptance in fully allogeneic renal versus cardiac allograft models by CD28-B7 T cell costimulatory blockade: role of thymus and spleen.
    Schaub M; Stadlbauer TH; Chandraker A; Vella JP; Turka LA; Sayegh MH
    J Am Soc Nephrol; 1998 May; 9(5):891-8. PubMed ID: 9596088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients.
    Stadlbauer TH; Schaub M; Korom S; Onodera K; Sayegh MH; Kupiec-Weglinski JW
    Transplantation; 1997 Dec; 64(12):1816-22. PubMed ID: 9422425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing.
    Bolling SF; Lin H; Wei RQ; Turka LA
    J Heart Lung Transplant; 1996 Sep; 15(9):928-35. PubMed ID: 8889989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
    Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P
    Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.
    Azuma H; Chandraker A; Nadeau K; Hancock WW; Carpenter CB; Tilney NL; Sayegh MH
    Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12439-44. PubMed ID: 8901600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival of rat to mouse cardiac xenografts with prolonged blockade of CD28-B7 interaction combined with peritransplant T-cell depletion.
    Rehman A; Tu Y; Arima T; Linsley PS; Flye MW
    Surgery; 1996 Aug; 120(2):205-12. PubMed ID: 8751584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.
    Sayegh MH; Akalin E; Hancock WW; Russell ME; Carpenter CB; Linsley PS; Turka LA
    J Exp Med; 1995 May; 181(5):1869-74. PubMed ID: 7536798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo.
    Akalin E; Chandraker A; Russell ME; Turka LA; Hancock WW; Sayegh MH
    Transplantation; 1996 Dec; 62(12):1942-5. PubMed ID: 8990393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic blockade of CD28-B7-mediated T-cell costimulation by CTLA4Ig reduces intimal thickening in MHC class I and II incompatible mouse heart allografts.
    Glysing-Jensen T; Räisänen-Sokolowski A; Sayegh MH; Russell ME
    Transplantation; 1997 Dec; 64(12):1641-5. PubMed ID: 9422395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD28 blockade alters cytokine mRNA profiles in cardiac transplantation.
    Lin H; Wei RQ; Goodman RE; Bolling SF
    Surgery; 1997 Aug; 122(2):129-37. PubMed ID: 9288115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation.
    Reddy B; Gupta S; Chuzhin Y; Kalergis AM; Budhai L; Zhang M; Droguett G; Horwitz MS; Chowdhury JR; Nathenson SG; Davidson A
    Transplantation; 2001 Mar; 71(6):801-11. PubMed ID: 11330546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.
    Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
    Transplantation; 2001 Oct; 72(8):1423-32. PubMed ID: 11685115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis.
    Kim KS; Denton MD; Chandraker A; Knoflach A; Milord R; Waaga AM; Turka LA; Russell ME; Peach R; Sayegh MH
    Am J Pathol; 2001 Mar; 158(3):977-86. PubMed ID: 11238045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged allograft survival but no tolerance induction by modulating CD28 antibody JJ319 after high-responder rat heart transplantation.
    Dengler TJ; Szabo G; Sido B; Nottmeyer W; Zimmerman R; Vahl CF; Hünig T; Meuer SC
    Transplantation; 1999 Feb; 67(3):392-8. PubMed ID: 10030284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The time course of CTLAIg effect on cardiac allograft rejection.
    Bolling SF; Lin H; Turka LA
    J Surg Res; 1996 Jun; 63(1):320-3. PubMed ID: 8661218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients.
    Sayegh MH; Zheng XG; Magee C; Hancock WW; Turka LA
    Transplantation; 1997 Dec; 64(12):1646-50. PubMed ID: 9422396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2.
    Onodera K; Chandraker A; Volk HD; Ritter T; Lehmann M; Kato H; Sayegh MH; Kupiec-Weglinski JW
    Transplantation; 1999 Jul; 68(2):288-93. PubMed ID: 10440403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion.
    Lin H; Bolling SF; Linsley PS; Wei RQ; Gordon D; Thompson CB; Turka LA
    J Exp Med; 1993 Nov; 178(5):1801-6. PubMed ID: 8228826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation and the CD28/CTLA4/B7 pathway.
    Alegre M; Fallarino F; Zhou P; Frauwirth K; Thistlethwaite J; Newell K; Gajewski T; Bluestone J
    Transplant Proc; 2001; 33(1-2):209-11. PubMed ID: 11266782
    [No Abstract]   [Full Text] [Related]  

  • 20. Toward novel antirejection strategies: in vivo immunosuppressive properties of CTLA4Ig.
    Perico N; Imberti O; Bontempelli M; Remuzzi G
    Kidney Int; 1995 Jan; 47(1):241-6. PubMed ID: 7731152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.